Peripheral Arterial Obliterative Disease: Cost of Illness in France

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.1 Part 2, 1998-01, pp. : 51-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cilostazol and peripheral arterial disease

By Pearce Lyndsay Ghosh Jonathan Counsell Andrew Serracino-Inglott Ferdinand

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2683-2690

Informa Healthcare

Access to resources Recommend Favorite

Hypertension in Peripheral Arterial Disease

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3615-3620

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidants in Peripheral Arterial Disease

Current Drug Targets, Vol. 4, Iss. 8, 2003-11 ,pp. : 651-655

Bentham Science Publishers

Access to resources Recommend Favorite

Cost of Illness of Crohn's Disease

By Bodger K.

PharmacoEconomics, Vol. 20, Iss. 10, 2002-01 ,pp. : 639-652

Adis International

Access to resources Recommend Favorite

Emerging drugs in peripheral arterial disease

By Tulsyan Nirman Ouriel Kenneth Kashyap Vikram S

Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. : 75-90

Informa Healthcare

Access to resources Recommend Favorite